Among patients with new-onset systemic lupus erythematosus (SLE), 23% experienced one or more thromboembolic events (TEs). The incidence of TEs in antiphospholipid antibody-positive patients diagnosed ...
AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
AstraZeneca ((AZN)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to ...
BOSTON, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that results from a Phase 3 ...
In a new study, researchers discovered a potential new gene biomarker, ELF1, a protein coding gene, that can be used to diagnose and evaluate people with systemic lupus erythematosus (SLE). The ...
Please provide your email address to receive an email when new articles are posted on . ATA3219 is an allogeneic CAR T-cell therapy being investigated in the treatment of SLE with lupus nephritis. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback